XCUR – Exicure Inc.
XCUR — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
14.15
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
1.27
Target Price
10.33
Analyst Recom
1
Performance Q
-60.9
Upside
-1,628.2%
Beta
3.62
Ticker: XCUR
20 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | XCUR | 1.63 | N/A | N/A | 0 |
| 2026-07-14 | XCUR | 1.705 | N/A | N/A | 0 |
| 2026-07-15 | XCUR | 1.63 | N/A | N/A | 0 |
| 2026-07-16 | XCUR | 1.6 | N/A | N/A | 0 |
| 2026-07-17 | XCUR | 1.72 | N/A | N/A | 0 |
| 2026-07-20 | XCUR | 1.89 | N/A | N/A | 0 |
| 2026-07-21 | XCUR | 1.9 | N/A | N/A | 0 |
| 2026-07-22 | XCUR | 1.71 | N/A | N/A | 0 |
| 2026-07-23 | XCUR | 1.71 | N/A | N/A | 0 |
| 2026-07-24 | XCUR | 1.73 | N/A | N/A | 0 |
| 2026-07-27 | XCUR | 1.74 | N/A | N/A | 0 |
| 2026-07-28 | XCUR | 1.71 | N/A | N/A | 0 |
| 2026-07-29 | XCUR | 1.73 | N/A | N/A | 0 |
| 2026-07-30 | XCUR | 1.61 | N/A | N/A | 0 |
| 2026-07-31 | XCUR | 1.63 | N/A | N/A | 0 |
| 2026-08-03 | XCUR | 1.51 | N/A | N/A | 0 |
| 2026-08-04 | XCUR | 1.55 | N/A | N/A | 0 |
| 2026-08-05 | XCUR | 1.57 | N/A | N/A | 0 |
| 2026-08-06 | XCUR | 1.33 | N/A | N/A | 0 |
| 2026-08-07 | XCUR | 1.305 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | XCUR | 1.65 | - | - | - |
| 2026-07-14 | XCUR | 1.66 | - | - | - |
| 2026-07-15 | XCUR | 1.62 | - | - | - |
| 2026-07-16 | XCUR | 1.59 | - | - | - |
| 2026-07-17 | XCUR | 1.65 | - | - | - |
| 2026-07-20 | XCUR | 1.89 | - | - | - |
| 2026-07-21 | XCUR | 1.90 | - | - | - |
| 2026-07-22 | XCUR | 1.71 | - | - | - |
| 2026-07-23 | XCUR | 1.71 | - | - | - |
| 2026-07-24 | XCUR | 1.74 | - | - | - |
| 2026-07-27 | XCUR | 1.73 | - | - | - |
| 2026-07-28 | XCUR | 1.72 | - | - | - |
| 2026-07-29 | XCUR | 1.74 | - | - | - |
| 2026-07-30 | XCUR | 1.60 | - | - | - |
| 2026-07-31 | XCUR | 1.64 | - | - | - |
| 2026-08-03 | XCUR | 1.59 | - | - | - |
| 2026-08-04 | XCUR | 1.59 | - | - | - |
| 2026-08-05 | XCUR | 1.51 | - | - | - |
| 2026-08-06 | XCUR | 1.31 | - | - | - |
| 2026-08-07 | XCUR | 1.27 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | XCUR | -31.43 | -0.01 | 0.16 |
| 2026-07-14 | XCUR | -31.43 | -0.01 | 0.16 |
| 2026-07-15 | XCUR | -31.41 | -0.01 | 0.16 |
| 2026-07-16 | XCUR | -31.43 | -0.01 | 0.16 |
| 2026-07-17 | XCUR | -31.41 | -0.01 | 0.16 |
| 2026-07-20 | XCUR | -31.42 | -0.01 | 0.16 |
| 2026-07-21 | XCUR | -10.65 | -0.01 | 0.16 |
| 2026-07-22 | XCUR | 0.00 | -0.01 | 0.16 |
| 2026-07-23 | XCUR | 0.00 | -0.01 | 0.16 |
| 2026-07-24 | XCUR | 0.00 | -0.01 | 0.16 |
| 2026-07-27 | XCUR | 0.00 | -0.02 | 14.15 |
| 2026-07-28 | XCUR | 0.00 | -0.02 | 14.15 |
| 2026-07-29 | XCUR | 0.00 | -0.02 | 14.15 |
| 2026-07-30 | XCUR | 0.00 | -0.02 | 14.15 |
| 2026-07-31 | XCUR | 0.00 | -0.02 | 14.15 |
| 2026-08-03 | XCUR | 0.00 | -0.02 | 14.15 |
| 2026-08-04 | XCUR | 0.00 | -0.02 | 14.15 |
| 2026-08-05 | XCUR | 0.00 | -0.02 | 14.15 |
| 2026-08-06 | XCUR | 0.00 | -0.02 | 14.15 |
| 2026-08-07 | XCUR | 0.00 | -0.02 | 14.15 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-0.02
Beta
3.62
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
4
Growth Score
Sentiment Score
1
Actual DrawDown %
99.4
Max Drawdown 5-Year %
-99.4
Target Price
10.33
P/E
Forward P/E
PEG
P/S
P/B
3.98
P/Free Cash Flow
EPS
-1.54
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.1
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
◆
XCUR
Healthcare
$1.31
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
20/20
Pullback
11/25
Volume
11/15
Valuation
12/20
TP/AR
2/10
Options
0/10
RSI
27.9
Range 1M
4.4%
Sup Dist
2.3%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
7/25
Growth
4/30
Estimates
0/20
Inst/Vol
0/15
Options
0/10
EPS Yr
0%
EPS NY
0%
52W%
0.4%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+688.5% upside
Quality
2/30
Valuation
16/30
Growth
0/25
Stability
4/10
LT Trend
4/5
Upside
+688.5%
Quality
4
Click a card to see score breakdown
Full Analysis →
XCUR — P/E HistoricalBiotechnology
Sector: Healthcare
Industry: Biotechnology
Employees: 2
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
XCUR
Latest News
—
Caricamento notizie per XCUR…
stock quote shares XCUR – Exicure Inc. Stock Price stock today
news today XCUR – Exicure Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch XCUR – Exicure Inc. yahoo finance google finance
stock history XCUR – Exicure Inc. invest stock market
stock prices XCUR premarket after hours
ticker XCUR fair value insiders trading